Adaptimmune

Adaptimmune

Adaptimmune

Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment
Suggest edits
Type
B2c
Founded
2008
Raised
$42M
Follow us
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1

Add info
Latest funding
$42,000,000
Post-IPO equity - 2017
Team Size
50+
Employees
I work here
Location
United Kingdom
Headquarters
Explore United Kingdom
$42,000,000 Post-IPO equity
biospace

Adaptimmune Announces Closing Of 42 Million Registered Direct Offering

Adaptimmune
Adaptimmune